Vertex Pharmaceuticals (VRTX) Cash & Equivalents Growth (3y) (2012 - 2026)
Vertex Pharmaceuticals (VRTX) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 24.73% |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | -40.88% |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | -28.55% |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | 21.66% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | -16.07% |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.55 Bn | 54.80 Bn | 3.31 Bn | -8.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.07% |
| Dec 31, 2025 | -21.48% |
| Sep 30, 2025 | -18.64% |
| Jun 30, 2025 | -17.02% |
| Mar 31, 2025 | -14.96% |
| Dec 31, 2024 | -12.39% |
| Sep 30, 2024 | -5.84% |
| Jun 30, 2024 | -8.93% |
| Mar 31, 2024 | 13.25% |
| Dec 31, 2023 | 20.08% |
| Sep 30, 2023 | 27.52% |
| Jun 30, 2023 | 28.08% |
| Mar 31, 2023 | 37.25% |
| Dec 31, 2022 | 50.05% |
| Sep 30, 2022 | 39.23% |
| Jun 30, 2022 | 38.23% |
| Mar 31, 2022 | 37.97% |
| Dec 31, 2021 | 36.87% |
| Sep 30, 2021 | 36.30% |
| Jun 30, 2021 | 41.39% |